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Photooxidation fprimaquine (1) and 5-hydroxyprimaquine (5) afforded a blue dye for which o-quinone 
structure 4 was elaborated. Similar oxidation of N-ethoxyacetylprimaquine (10) afforded o-quinone 11. 
Tissue schizontocidal activity of 4 and 11, and bisquinolylmethine 3 prepared earlier, showed that none of 
them had noteworthy antimalarial ctivity, but all three produced methemoglobin. 
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1. INTRODUCTION 
Hemolytic and antimalarial effects of 8-amino- 
quinoline antimalarials appear to be intimately 
related, and suggest that both depend on the for- 
mation of reversible redox intermediates formed 
during biotransformation f the drug in the host 
[1]. Demethylprimaquine is more potent han the 
parent compound in vitro against erythrocytic 
forms of P. gailinaceum, and potency is further in- 
creased by the addition of another hydroxy group 
present in 5-hydroxydemethylprimaquine (5) [2]. 
An o-quinone obtained by metabolic conversion of 
the chemically related antimalarial pamaquine was 
isolated and found to be several times more potent 
than the parent drug in vitro [3]. Side chain 
degradation of primaquine (1), on the other hand, 
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a major metabolic pathway, afforded a desamino 
carboxylic acid [4] found to be inactive as a tissue 
schizontocide [5]. N-acylated primaquines are also 
inactive tissue schizontocides in vitro which sup- 
ports the view that the terminal amino group in the 
side chain of primaquine may be necessary for an- 
timalarial activity [5]. Further elucidation of anti- 
malarial and possibly associated hemolytic effects 
present in oxidation products of primaquine [6] 
suggested a study of several compounds obtained 
from 1 and its N-acylated analogs by photo- 
chemical oxidation. This included a blue dye for 
which Strother et al. [6] proposed the tricyclic 
quinonimine structure 2, now revised to that of o- 
quinone 4, readily obtained from 5-hydroxyde- 
methylprimaquine (5) as described here. Also in- 
cluded in this study was the quinoline-5,6-dione 
11, obtained by photooxidation f the ethoxyacet- 
amide 10, an analog of the microbial metabolite N- 
acetylprimaquine [7]. A third compound also in- 
vestigated was the diquinolinylmethine blue dye 3, 
prepared earlier from 10 by photooxidation i
chloroform solution [8]. 
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2. MATERIALS AND METHODS 
2.1. Chemistry (figs 1,2) 
Blue compound 4 was prepared as follows: 
5-hydroxy-6-demethylprimaquine trihydrobro- 
mide (5- 3HBr) [9] (500 mg) was dissolved in water 
(10 ml), made alkaline with concentrated aqueous 
ammonia (pH 9), and extracted 3 times with 
methylene chloride in an argon atmosphere. The 
combined organic extracts were dried (Na2SO4), 
diluted with methylene chloride to 150 ml, placed 
in a 500 ml Erlenmeyer flask and exposed to direct 
sunlight for 2 h with occasional stirring. The solu- 
tion turned from yellow to deep blue. The solution 
was then evaporated to dryness and 
chromatographed on an SiO2 column using 1%0 
methanol in methylene chloride as an eluent o af- 
ford 120 mg (47%) of a deep blue amorphous solid 
4:C14HIsN302 (257.14) - Calcd. C, 65.33; H, 
5.88; N, 16.34. Found C, 64.76; H, 5.93; N, 15.70 
(the microanalysis was performed by Dr F. 
Scheidl, Hoffmann-La Roche, Inc., Nutley, N J). 
CI-MS, m/e 258 (M++ 1), EI-MS 257; UV 
(MeOH) max 239, 270, 310, 360 (sh) and 589 nm; 
IR (CHCI3) 3300, 2930, 2850, 1690, 1610, 1585, 
1540, 1500, 1435, 1360, 1310, 1180 and 1095 cm -1. 
The 13C-NMR data of this compound as described 
by Strother et al. [6] were essentially confirmed 
and are listed in table 1. 
Methylation of 4 with ethereal diazomethane in 
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Fig.2. 
methanol afforded O-methyl ether 6 as a yellow 
substance and separated from other products by 
preparative TLC (SiO2, 1%0 MeOH in CHC13): CI- 
MS, m/e 272 (M + + 1); UV (MeOH) max 252, 315 
and 410 nm; IR (CHC13) 3300, 2980, 2940, 1620, 
1590, 1555, 1500, 1430, 1365, 1335, 1310, 1290, 
1150 and 1090cm -1. Absence of the carbonyl 
signal present at 1690 cm -1 in 4 confirmed its 
structure. 
Acetylation of 4 with acetic anhydride afforded 
the N-acetyl derivative 7 as an orange, amorphous 
solid: CI-MS, m/e 300 (M + + 1); UV (MeOH) max 
233,276, 297 and 448 nm; IR (CHCI3) 3280, 2975, 
2920, 1700, 1645, 1595, 1555, 1515, 1380, 1345, 
1315 and 1290 cm -1. Reduction of 4 over a Pt 
catalyst in methanol afforded hydroquinone 8 not 
isolated since the yellow solution of 8 rapidly 
turned blue when exposed to air. Reduction of 4 
over a Pt catalyst in acetic anhydride afforded 
yellow triacetate 9:CI-MS, m/e 386 (M ÷ + I); UV 
O 
/ 
f CH~ - 
4 
HN H--N 
J CH3 0 
CH30 1. R TM R 3= H, R 2= CH 3 
CH 5. R 1= OH, R 2= R 3= H 
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Fig. 1. 
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Table 1 
~3C-NMR assignments for blue dye 4 a 
Carbon no. Chemical shift 
2 151.7 (1) 
3 124.9 (1) 
4 134.5 (1) 
4a 126.0 (0) b 
5 180.6 (0) 
6 172.0 (0) 
7 124.2 (0) c 
8 145.7 (0) d 
8a 148.5 (0) e 
1' 48.6 (1) 
2' 39.4 (2) 
3' 23.5 (2) 
4' 50.2 (2) 
5' 22.4 (3) 
a Assignments were confirmed by APT, DEPTGL, 
COSY and HETCOR experiments and agree with 
those reported [6] except for quaternary signals C-4a, 
C-8a, C-7 and C-8. The data were generated in CDC13 
on a Varian VXR 300 NMR spectrometer. Assign- 
ments for C-4a, C-8a, C-7 and C-8 were established by 
observing the fully coupled carbon NMR spectrum and 
by conducting low-power selective long-range decou- 
piing experiments (LSPD) 
b C-4a is three bond coupled to H-3; irradiation (LSPD) 
at H-3 (7.37) collapses the doublet o a singlet 
c C-7 appears as a double doublet in the coupled spec- 
trum being coupled to H-4' and the NH; irradiation 
(LSPD) at H-4' (3.15) and NH (7.49) collapsed the 
signal to a doublet 
a C-8 appears as a singlet in the coupled spectrum and is 
unaffected by irradiation (LSPD) at H-2 (8.60), H-3 
(7.37), H-4 (8.16), H-I '  (5.35), H-4' (3.15), NH (7.49) 
and NH (3.74) 
e C-8a appears a complex multiplet in the coupled spec- 
trum; irradiation (LSPD) at H-2, H-4 and NH (7.49) 
simplifies the pattern 
(MeOH) max 264, 343 and 368 nm. Blue dye 4 is 
further oxidized by air, turning the blue color on 
TLC plates into purple. The reactions mentioned 
above fully support o-quinone structure 4 for the 
blue dye. This material is quite unpolar and moves 
on TLC plates faster than 1 or 7, indicating, 
together with the strong absorption band at 
3300 cm -1 (IR), strong hydrogen bonding between 
the amino group and the adjacent carbonyl group. 
Photooxidation of amide 10 deposited on a silica 
gel surface and exposed to sunlight for several 
Table 2 
IDa0 and IDgo values of primaquine diphosphate and ox- 
idation products 3, 4 and 11 
Compound IDs0 IDg0 
(mg- 1-1) 
Primaquine 0.015 0.2 
3 3 12 
4 3 22 
11 5.8 25 
hours in the presence of air afforded the orange 
quinone 11 which served as an important reference 
substance: CI-MS, role 346 (M + + 1); UV (MeOH) 
max 233,275,296 and 446 nm and identical to that 
of compound 7. 
2.2. Biological testing 
Biological materials and techniques used for 
cultivating hepatocytes and performing chemo- 
therapy tests were the same as described [5] with 
the compounds dissolved in absolute alcohol. 
The effect of the test compounds on the in vitro 
formation of methemoglobin was studied using a 
modification of the procedure of Fraser and Vesell 
[10]. Whole blood was collected from New 
Zealand rabbits using heparin as the anti- 
coagulant, he erythrocytes were washed twice with 
0.8°7o NaCI in 0.01 M phosphate buffer (pH 7.4), 
and then reconstituted as a 50o7o dispersion in 
saline phosphate buffer. The incubations were 
conducted for 1 h at 37°C in a shaker bath using 
0.5 ml washed erythrocytes and 0.5 ml test com- 
pound (4 × 10 -4 M) dissolved in 0.04 M glucose, 
0.01 M phosphate buffer (pH 7.4). After incuba- 
tion, 0.1 ml erythrocyte suspension was hemolyzed 
Table 3 
Cell toxicity of primaquine diphosphate and oxidation 
products 3, 4 and 11 
Compound 1 5 10 20 50 100 
(mg- 1- l) 
Primaquine HT HT HT 
3 0 0 V HT 
4 0 0 0 0 HT 
11 0 0 0 0 NT 
HT, high toxicity; 0, no toxicity; V, dead cells but intra- 
cytoplasmic vacuoles; NT, not tested 
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C(6), or vice versa, before compound 4 is formed. 
Blue dye 4 is strongly hydrogen bonded 
( -  NH .... O = ) with the blue color disappearing on 
O-methylation or N-acetylation, and its structure 
is somewhat reminescent to that of ' indanthrone'. 
Photooxidation of N-acylated primaquines pro- 
vides a simple entry into quinoline-5,6-diones, so 
far difficult to obtain. 
4. CONCLUSIONS 
It would appear that the types of structures seen 
in 4 and 11 or in the dimeric structure 3 are not 
associated with the schizontocidal activity of 
primaquine given the low activity of the three 
model compounds compared to primaquine. Con- 
sidering the low schizontocidal activity of N- 
acylated primaquine (IDso = 3 mg/l [5]), however, 
the lack of an amide side chain in 3, 4, and 11 may 
preclude observation of antimalarial activity. 
The toxicity of primaquine towards hepatocytes 
was found to be fairly high while those of 3, 4, and 
11 were fairly low and comparable to that 
previously reported for N-acylated primaquine [7]. 
Thus, it would appear that quinone or dimeric 
heterocyclic structures alone are not sufficient for 
the expression of hepatocyte toxicity and anti- 
malarial activity. 
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